DEC 11, 2017 9:44 AM PST

"Death Receptors" Measure Risk of Heart Disease and Type 2 Diabetes

WRITTEN BY: Kara Marker

So-called “death receptors” found in the blood are predictive of an individual’s risk of heart disease and type 2 diabetes, according to a new study from Lund University published in the journal EBioMedicine.

Human beta cells and insulin granules. Credit: Wikimedia user Wikimaji

TNFR-1, TRAILR-2, and FAS are all part of the death receptor family, members of which trigger apoptosis, a form of programmed cell death. They do so in response to stress experienced by blood vessels and beta cells, which produce insulin. This stress is a result of other risk factors associated with heart disease and diabetes, including high blood sugar and high blood fat.

"When the beta cells are damaged, the production of insulin decreases, which increases the risk of diabetes. The damage activates repair processes in the blood vessels. If these are not properly resolved, this usually leads to the development of plaque in the blood vessels,” explained study leader Jan Nilsson. “The formation of cracks in this plaque is the primary cause of [heart attack] and stroke."

Nilsson’s study asked this question: Can death receptors such as TNFR-1, TRAILR-2, and FAS predict the risk of heart disease and type 2 diabetes? The study also included an analysis of links between disease and other risk factors like age, BMI, blood pressure, blood fats and blood sugar. With 4,742 participants, the study successfully compared death receptor levels to the risk of diabetes, heart attack, and stroke.

For people who already had type 2 diabetes, researchers saw high levels of death receptors, which indicates “increased cell stress and risk of damage to different organs.” For people without a diabetes diagnosis but who still had high levels of death receptors, their presence indicated their elevated risk of developing diabetes and heart disease in the future.

Interestingly, one limitation of the study was that researchers could not use levels of death receptors to predict the risk of heart disease for people who already have diabetes, only for people without diabetes. “We don't yet really understand why, but it could be the case that the level of the biomarkers, i.e. death receptors, among diabetics is already very high,” Nilsson explained.

These findings suggest that a measurement of death receptors could be used to check the progress of existing heart disease or diabetes as well as to predict risk of future disease. “We could at an early stage get an idea of whether treatment of risk factors reduces damage to beta cells and blood vessel walls by monitoring the death receptors in the blood,” Nilsson said.

Nilsson and others hope that their findings could help with new clinical studies and future development of new drugs.

Sources: Lund University, Cell Signaling Technology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 24, 2019
Cardiology
JUN 24, 2019
Performance Enhancing Bacteria?
Attempts by athletes to increase their performance occasionally goes too far. This is the case in endless doping scandals across all types of elite athleti...
JUL 26, 2019
Cardiology
JUL 26, 2019
When Does Smartphone Usage Increase Obesity Risk?
It’s well known that decreased physical activity and obesity are not good for the heart. As more people use smartphones more often, they are moving a...
SEP 07, 2019
Cardiology
SEP 07, 2019
Your Brain On Cardiovascular Exercise
There is an increasing number of studies that explore the connection between exercise and the brain. These studies have revealed some fascinating connectio...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Therapeutic Targets Inflammation Associated with Genetic Heart Disease
Often times when young athletes collapse during the game it is due to sudden cardiac death as a result of the inherited arrhythmogenic cardiomyopathy (ACM)...
OCT 25, 2019
Cardiology
OCT 25, 2019
Cardiac Mapping for Arrhythmia Diagnosis
Cardiac mapping is an essential diagnostic tool. These imagining tools are used for diagnosing arrhythmias in the heart. Cardiac mapping can be done in sev...
JAN 06, 2020
Cardiology
JAN 06, 2020
Online Therapy Treats Depression in Heart Disease Patients
People suffering from cardiovascular disease (CVD) often suffer from depression too- something that can lead to a vicious cycle in which CVD can be negativ...
Loading Comments...